肝细胞癌临床诊疗的研究进展  

Research Progress in Clinical Diagnosis and Treatment of Hepatocellular Carcinoma

作　　者：赵庆江 田大广[2] Zhao Qing-jiang;Tian Da-guang(Kunming Medical University,Kunming 650500,Yunnan Province,China;First Ward of Hepatobiliary and Pancreatic Surgery Department,the Second Affiliated Hospital of Kunming Medical University,Kunming 650000,Yunnan Province,China)

机构地区：[1]昆明医科大学,云南昆明650500 [2]昆明医科大学第二附属医院肝胆胰外科一病区,云南昆明650000

出　　处：《中国社区医师》2023年第11期11-13,21,共4页Chinese Community Doctors

摘　　要：肝癌是一种威胁人类健康的恶性肿瘤,肝细胞癌(HCC)是最常见的肝癌类型,约占所有肝癌的90%。乙型肝炎病毒和丙型肝炎病毒感染是HCC发生的主要危险因素,酒精性肝炎、脂肪性肝炎相关的HCC具有特殊的分子发病机制,分子生物学的高度发展和传统诊断方法的结合有助于HCC患者的精准治疗。该文对HCC的流行病学、病因学、病理生理学、诊断方式、治疗方式作一综述。Liver cancer is a malignancy threatening human health.Hepatocellular carcinoma(HCC)is the most common type of liver cancer,accounting for approximately 90%of the overall liver cancer.Hepatitis B virus and hepatitis C virus infections are the major risk factors for HCC occurrence,and alcoholic hepatitis and steatohepatitis associated HCC has a special molecular pathogenesis mechanism.The high development of molecular biology and the combination of traditional diagnostic methods contribute to the accurate treatment of HCC patients.This article reviews the epidemiology,etiology,pathophysiology,diagnosis method and treatment method of HCC.

关 键 词：肝细胞癌 局部消融 化疗栓塞 

分 类 号：R735.7[医药卫生—肿瘤]